361

  • Internet ҳавола
  • DOI
  • UzSCI тизимида яратилган сана 10-04-2020
  • Ўқишлар сони 352
  • Нашр санаси 22-04-2017
  • Мақола тилиRus
  • Саҳифалар сони213-215
Калит сўзлар
№ Муаллифнинг исми Лавозими Ташкилот номи
1 Xusinova S.A.
№ Ҳавола номи
1 1. Бутрова С.А. Эффективность Глюкофажа в профилактике сахарного диабета 2 типа. РМЖ. 2003, № 27, с. 1494-1498. 2. Глобальный доклад по диабету, ВОЗ, 2016 г. 3. Дедов И.И., Шестакова М.В., Галстян Г.Р. Распространенность сахарного диабета 2типа у взрослого населения России (исследование NATION). – Сахарный диабет. –2016. – 19 (2). – с. 104-112.CDC (Centers for Disease Control and Prevention). Awareness of prediabetes-UnitedStates, 2005–2010. MMWR Morb Mortal Wkly Rep. 2013;62(11):209–212. 4. Дедов И.И., Сунцов Ю.И. Эпидемиология сахарного диабета. Сахарный диабет. Руковод-ство для врачей. авт. Дедов И. И., Шестакова М.В.Универсум Паблишинг. М.,2003; 75–93. 5. ADA. Prevention or delay of type 2 diabetes. Diabetes Care. 2016b;39(suppl 1):S36–S38. 6. Babey SH, Wolstein J, Diamant AL. Prediabetes in California: Nearly Half of California Adults on Path to Diabetes. Policy Brief UCLA Cent Health Policy Res. 2016 Mar;(PB2016-1):1-8. 7. Bergman M. Pathophysiology of prediabetes and treatment implications for the prevention of type 2 diabetes mellitus. Endocrine. 2013 Jun;43(3):504-13. 8. Isomaa B., Almgren P., Tuomi T., Forsen B. et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care, 2001; 24: 683–9. 9. Nathan DM, Davidson MB, DeFronzo RA, et al; American Diabetes Association.Impaired fasting glucose and impaired glucose tolerance: implications for care. DiabetesCare. 2007;30(3):753–759. 10. Nathan D. et al. Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy: A consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes // Diabetes Care, 2009, vol. 32, p-1-11. 11. Kanat M, Mari A, Norton L, et al. Distinct β-cell defects in impaired fasting glucose and impaired glucose tolerance. Diabetes. 2012;61(2):447–453. 14. Ramachandran A., Snehalatha C., Yamuna A. Cost-Effectiveness of the Interventions in the Primary Prevention of Diabetes Among Asian Indians Within-trial results of the Indian Diabetes Prevention Programme (IDPP). Diabetes Care 2007; 30: 2548–2552.
Кутилмоқда